RFA
Reilly Financial Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $12K | Hold |
111
| – | – | ﹤0.01% | 689 |
|
|
2021
Q3 | $14K | Hold |
111
| – | – | ﹤0.01% | 604 |
|
|
2021
Q2 | $15K | Sell |
111
-60
| -35% | -$8.11K | ﹤0.01% | 618 |
|
|
2021
Q1 | $23K | Buy |
171
+60
| +54% | +$8.07K | ﹤0.01% | 518 |
|
|
2020
Q4 | $16K | Sell |
111
-185
| -63% | -$26.7K | ﹤0.01% | 539 |
|
|
2020
Q3 | $33K | Sell |
296
-27
| -8% | -$3.01K | ﹤0.01% | 368 |
|
|
2020
Q2 | $36K | Hold |
323
| – | – | ﹤0.01% | 356 |
|
|
2020
Q1 | $25K | Sell |
323
-13
| -4% | -$1.01K | ﹤0.01% | 400 |
|
|
2019
Q4 | $32K | Sell |
336
-144,949
| -100% | -$13.8M | ﹤0.01% | 413 |
|
|
2019
Q3 | $11.1M | Buy |
145,285
+65
| +0% | +$4.96K | 1.36% | 33 |
|
|
2019
Q2 | $12.7M | Sell |
145,220
-38,949
| -21% | -$3.42M | 1.6% | 16 |
|
|
2019
Q1 | $16.7M | Sell |
184,169
-1,035
| -0.6% | -$93.7K | 2.16% | 5 |
|
|
2018
Q4 | $13.3M | Buy |
185,204
+29,479
| +19% | +$2.12M | 1.94% | 7 |
|
|
2018
Q3 | $14.9M | Buy |
155,725
+3,217
| +2% | +$308K | 1.98% | 8 |
|
|
2018
Q2 | $14.5M | Buy |
152,508
+26,641
| +21% | +$2.54M | 2.06% | 6 |
|
|
2018
Q1 | $11M | Buy |
125,867
+2,277
| +2% | +$200K | 1.54% | 25 |
|
|
2017
Q4 | $10.5M | Sell |
123,590
-3,637
| -3% | -$309K | 1.49% | 33 |
|
|
2017
Q3 | $11M | Buy |
127,227
+350
| +0.3% | +$30.3K | 1.65% | 26 |
|
|
2017
Q2 | $9.79M | Buy |
+126,877
| New | +$9.79M | 1.5% | 38 |
|